Abstract Library

Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.

Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.

ENETS Abstract Search

#2191 Endocrine Paraneoplastic Syndromes in Patients with Neuroendocrine Neoplasms

Introduction: Endocrine paraneoplastic syndromes (ePNS) result from production of bioactive substances from tumours not related to their expected tissue of origin. Neuroendocrine neoplasms (NENs) have been associated with ectopic secretion of several hormones, but the prevalence of ePNS has only been described in a small number of studies.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Chatzellis E, Alexandraki K, Angelousi A, Tsoli M, Kaltsatou M,

Keywords: paraneoplastic syndromes, neuroendocrine neoplasms, ectopic secretion,

#1880 Dedifferentiation of Metastatic Pancreatic Neuroendocrine Neoplasms

Introduction: Neuroendocrine neoplasms (NENs) exhibit significant differences in growth behavior. Their metastatic disease may dedifferentiate presenting a more aggressive biological behavior

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Alexandraki K, Boutzios G, Kaltsatou M, Nikolopoulos G, Moschouris P,

Keywords: dedifferentiation,

#1876 Multiple Endocrine Neoplasia Type 1 (MEN1): The Experience of a Referral Center in Greece

Introduction: Multiple endocrine neoplasia type 1 (MEN1) is a genetic disorder involving mainly parathyroid, pituitary and pancreatic neuroendocrine neoplasms (pNENs)

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Alexandraki K, Chrysochoou M, Kaltsatou M, Tsoli M, Nikolopoulos G,

Keywords: MEN1,

#1535 VIPomas, a Rare Entity

Introduction: VIP secreting pancreatic neuroendocrine tumors(pNETs) are rare and controlled studies are lacking.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Boutzios G, Alexandraki K, Kaltsatou M, Nikolopoulos G, Moschouris P,

Keywords: VIPoma, pNET,

#1014 Sunitinib Induced Hypocalcaemia During Treatment of Pancreatic Neuroendocrine Tumors (pNETs)

Introduction: Sunitinib is an oral multitargeted tyrosine kinase inhibitor used for pNET treatment.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Alexandraki K, Karnezis J, Kaltsatou M, Chatzelis E, Tsoli M,

Keywords: Sunitinib, pNET, hypocalcemia,